CATH Superfamily 2.60.120.40
The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 7: Tumor necrosis factor
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 15 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Tumor necrosis factor receptor binding GO:0005164
Interacting selectively and non-covalently with the tumor necrosis factor receptor.
|
8 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P06804 (/IDA) P06804 (/IDA) P16599 (/IDA) |
Tumor necrosis factor receptor binding GO:0005164
Interacting selectively and non-covalently with the tumor necrosis factor receptor.
|
8 | P01375 (/IPI) P01375 (/IPI) P01375 (/IPI) P01375 (/IPI) P01375 (/IPI) P06804 (/IPI) P06804 (/IPI) P16599 (/IPI) |
Protease binding GO:0002020
Interacting selectively and non-covalently with any protease or peptidase.
|
7 | P01375 (/IPI) P01375 (/IPI) P01375 (/IPI) P01375 (/IPI) P01375 (/IPI) P06804 (/IPI) P06804 (/IPI) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
7 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P06804 (/IDA) P06804 (/IDA) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
7 | P01375 (/IPI) P01375 (/IPI) P01375 (/IPI) P01375 (/IPI) P01375 (/IPI) P06804 (/IPI) P06804 (/IPI) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
5 | P01375 (/IPI) P01375 (/IPI) P01375 (/IPI) P01375 (/IPI) P01375 (/IPI) |
Transcription regulatory region DNA binding GO:0044212
Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Protease binding GO:0002020
Interacting selectively and non-covalently with any protease or peptidase.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Tumor necrosis factor receptor binding GO:0005164
Interacting selectively and non-covalently with the tumor necrosis factor receptor.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Tumor necrosis factor receptor binding GO:0005164
Interacting selectively and non-covalently with the tumor necrosis factor receptor.
|
2 | P06804 (/TAS) P06804 (/TAS) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Transcription regulatory region DNA binding GO:0044212
Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
1 | P16599 (/TAS) |
There are 363 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Necroptotic signaling pathway GO:0097527
A series of molecular signals which triggers the necroptotic death of a cell. The pathway starts with reception of a signal, is characterized by activation of receptor-interacting serine/threonine-protein kinase 1 and/or 3 (RIPK1/3, also called RIP1/3), and ends when the execution phase of necroptosis is triggered.
|
121 |
A0A2I3HVV8 (/ISS)
B6E118 (/ISS)
B6ZND6 (/ISS)
D6QYX8 (/ISS)
D7REL0 (/ISS)
D7REL0 (/ISS)
D7UU02 (/ISS)
D7UU02 (/ISS)
D7UU02 (/ISS)
D7UU02 (/ISS)
(111 more) |
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
|
79 |
O35734 (/ISS)
O77510 (/ISS)
O77764 (/ISS)
P01375 (/ISS)
P01375 (/ISS)
P01375 (/ISS)
P01375 (/ISS)
P01375 (/ISS)
P04924 (/ISS)
P04924 (/ISS)
(69 more) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
61 |
O35734 (/ISS)
O77510 (/ISS)
O77764 (/ISS)
P06804 (/ISS)
P06804 (/ISS)
P13296 (/ISS)
P19101 (/ISS)
P29553 (/ISS)
P29553 (/ISS)
P48094 (/ISS)
(51 more) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
61 |
O35734 (/ISS)
O77510 (/ISS)
O77764 (/ISS)
P06804 (/ISS)
P06804 (/ISS)
P13296 (/ISS)
P19101 (/ISS)
P29553 (/ISS)
P29553 (/ISS)
P48094 (/ISS)
(51 more) |
Negative regulation of protein complex disassembly GO:0043242
Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components.
|
61 |
O35734 (/ISS)
O77510 (/ISS)
O77764 (/ISS)
P06804 (/ISS)
P06804 (/ISS)
P13296 (/ISS)
P19101 (/ISS)
P29553 (/ISS)
P29553 (/ISS)
P48094 (/ISS)
(51 more) |
Positive regulation of protein complex disassembly GO:0043243
Any process that activates or increases the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components.
|
61 |
O35734 (/ISS)
O77510 (/ISS)
O77764 (/ISS)
P06804 (/ISS)
P06804 (/ISS)
P13296 (/ISS)
P19101 (/ISS)
P29553 (/ISS)
P29553 (/ISS)
P48094 (/ISS)
(51 more) |
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
|
61 |
O35734 (/ISS)
O77510 (/ISS)
O77764 (/ISS)
P06804 (/ISS)
P06804 (/ISS)
P13296 (/ISS)
P19101 (/ISS)
P29553 (/ISS)
P29553 (/ISS)
P48094 (/ISS)
(51 more) |
Positive regulation of JUN kinase activity GO:0043507
Any process that activates or increases the frequency, rate or extent of JUN kinase activity.
|
61 |
O35734 (/ISS)
O77510 (/ISS)
O77764 (/ISS)
P06804 (/ISS)
P06804 (/ISS)
P13296 (/ISS)
P19101 (/ISS)
P29553 (/ISS)
P29553 (/ISS)
P48094 (/ISS)
(51 more) |
Positive regulation of inflammatory response GO:0050729
Any process that activates or increases the frequency, rate or extent of the inflammatory response.
|
10 | P16599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) |
Production of molecular mediator involved in inflammatory response GO:0002532
The synthesis or release of any molecular mediator of the inflammatory response following an inflammatory stimulus, resulting in an increase in its intracellular or extracellular levels.
|
9 | Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) |
Positive regulation of plasminogen activation GO:0010756
Any process that increases the rate, frequency or extent of plasminogen activation. Plasminogen activation is the process in which plasminogen is processed to plasmin.
|
9 | Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) |
Positive regulation of triglyceride metabolic process GO:0090208
Any process that increases the frequency, rate or extent of the chemical reactions and pathways involving triglyceride, any triester of glycerol.
|
9 | Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) |
Negative regulation of lactation GO:1903488
Any process that stops, prevents or reduces the frequency, rate or extent of lactation.
|
9 | Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) |
Negative regulation of feeding behavior GO:2000252
Any process that stops, prevents or reduces the frequency, rate or extent of feeding behavior.
|
9 | Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) Q06599 (/IMP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
8 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P06804 (/IDA) P06804 (/IDA) P16599 (/IDA) |
Positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123
Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling.
|
8 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P06804 (/IDA) P06804 (/IDA) P16599 (/IDA) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
8 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P06804 (/IDA) P06804 (/IDA) P16599 (/IDA) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
7 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P06804 (/IDA) P06804 (/IDA) |
Activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006919
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
|
7 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P06804 (/IDA) P06804 (/IDA) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
7 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P06804 (/IDA) P06804 (/IDA) |
Positive regulation of interleukin-6 production GO:0032755
Any process that activates or increases the frequency, rate, or extent of interleukin-6 production.
|
7 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P06804 (/IDA) P06804 (/IDA) |
Positive regulation of heterotypic cell-cell adhesion GO:0034116
Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
|
7 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P06804 (/IDA) P06804 (/IDA) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
7 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P06804 (/IDA) P06804 (/IDA) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
7 | P01375 (/IGI) P01375 (/IGI) P01375 (/IGI) P01375 (/IGI) P01375 (/IGI) P06804 (/IGI) P06804 (/IGI) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
6 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P16599 (/IDA) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
6 | P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P16599 (/IMP) |
Positive regulation of nitric-oxide synthase activity GO:0051000
Any process that activates or increases the activity of the enzyme nitric-oxide synthase.
|
6 | P01375 (/IC) P01375 (/IC) P01375 (/IC) P01375 (/IC) P01375 (/IC) P16599 (/IC) |
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
|
6 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P16599 (/IDA) |
Positive regulation of protein transport GO:0051222
Any process that activates or increases the frequency, rate or extent of the directed movement of a protein into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
6 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P16599 (/IDA) |
MAPK cascade GO:0000165
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
5 | P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) |
Activation of MAPKKK activity GO:0000185
Any process that initiates the activity of the inactive enzyme MAP kinase kinase kinase (MAPKKK).
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Activation of MAPK activity GO:0000187
The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Microglial cell activation GO:0001774
The change in morphology and behavior of a microglial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Microglial cell activation GO:0001774
The change in morphology and behavior of a microglial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
5 | P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) |
Positive regulation of cytokine production GO:0001819
Any process that activates or increases the frequency, rate or extent of production of a cytokine.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Chronic inflammatory response to antigenic stimulus GO:0002439
A chronic inflammatory response to an antigenic stimulus. A chronic inflammatory response persists indefinitely during days, weeks, or months in the life of an individual.
|
5 | P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) |
Negative regulation of cytokine secretion involved in immune response GO:0002740
Any process that stops, prevents, or reduces the frequency, rate, or extent of cytokine secretion contributing to an immune response.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
I-kappaB kinase/NF-kappaB signaling GO:0007249
The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Extrinsic apoptotic signaling pathway via death domain receptors GO:0008625
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with a ligand binding to a death domain receptor on the cell surface, and ends when the execution phase of apoptosis is triggered.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Extrinsic apoptotic signaling pathway via death domain receptors GO:0008625
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with a ligand binding to a death domain receptor on the cell surface, and ends when the execution phase of apoptosis is triggered.
|
5 | P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) |
Response to virus GO:0009615
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Response to salt stress GO:0009651
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating an increase or decrease in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
5 | P01375 (/IGI) P01375 (/IGI) P01375 (/IGI) P01375 (/IGI) P01375 (/IGI) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
5 | P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
5 | P01375 (/IGI) P01375 (/IGI) P01375 (/IGI) P01375 (/IGI) P01375 (/IGI) |
Regulation of tumor necrosis factor-mediated signaling pathway GO:0010803
Any process that modulates the rate or extent of the tumor necrosis factor-mediated signaling pathway. The tumor necrosis factor-mediated signaling pathway is the series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Negative regulation of lipid storage GO:0010888
Any process that decreases the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development.
|
5 | P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) |
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Cytokine-mediated signaling pathway GO:0019221
A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Sequestering of triglyceride GO:0030730
The process of binding or confining any triester of glycerol such that it is separated from other components of a biological system.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Cortical actin cytoskeleton organization GO:0030866
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of actin-based cytoskeletal structures in the cell cortex, i.e. just beneath the plasma membrane.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of protein complex assembly GO:0031334
Any process that activates or increases the frequency, rate or extent of protein complex assembly.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of fever generation GO:0031622
Any process that activates or increases the frequency, rate, or extent of fever generation.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Negative regulation of interleukin-6 production GO:0032715
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of chemokine production GO:0032722
Any process that activates or increases the frequency, rate, or extent of chemokine production.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of interleukin-8 production GO:0032757
Any process that activates or increases the frequency, rate, or extent of interleukin-8 production.
|
5 | P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) |
Receptor biosynthetic process GO:0032800
The chemical reactions and pathways resulting in the formation of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Tumor necrosis factor-mediated signaling pathway GO:0033209
A series of molecular signals initiated by the binding of a tumor necrosis factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
5 | P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) |
Tumor necrosis factor-mediated signaling pathway GO:0033209
A series of molecular signals initiated by the binding of a tumor necrosis factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Negative regulation of myosin-light-chain-phosphatase activity GO:0035509
Any process that stops, prevents, or reduces the frequency, rate or extent of myosin-light-chain-phosphatase activity.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of tyrosine phosphorylation of STAT protein GO:0042531
Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of programmed cell death GO:0043068
Any process that activates or increases the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Regulation of I-kappaB kinase/NF-kappaB signaling GO:0043122
Any process that modulates I-kappaB kinase/NF-kappaB signaling.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123
Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123
Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Negative regulation of protein complex disassembly GO:0043242
Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of protein complex disassembly GO:0043243
Any process that activates or increases the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043280
Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Protein kinase B signaling GO:0043491
A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
|
5 | P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) |
Positive regulation of JUN kinase activity GO:0043507
Any process that activates or increases the frequency, rate or extent of JUN kinase activity.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Negative regulation of viral genome replication GO:0045071
Any process that stops, prevents, or reduces the frequency, rate or extent of viral genome replication.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of chemokine biosynthetic process GO:0045080
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of chemokines.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of interleukin-6 biosynthetic process GO:0045410
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-6.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Positive regulation of interleukin-8 biosynthetic process GO:0045416
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of nitric oxide biosynthetic process GO:0045429
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Regulation of fat cell differentiation GO:0045598
Any process that modulates the frequency, rate or extent of adipocyte differentiation.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
|
5 | P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) |
Positive regulation of osteoclast differentiation GO:0045672
Any process that activates or increases the frequency, rate or extent of osteoclast differentiation.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of cell adhesion GO:0045785
Any process that activates or increases the frequency, rate or extent of cell adhesion.
|
5 | P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) |
Positive regulation of protein kinase activity GO:0045860
Any process that activates or increases the frequency, rate or extent of protein kinase activity.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Positive regulation of receptor signaling pathway via JAK-STAT GO:0046427
Any process that activates or increases the frequency, rate or extent of the JAK-STAT signaling pathway activity.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Astrocyte activation GO:0048143
A change in morphology and behavior of an astrocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
5 | P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) |
Embryonic digestive tract development GO:0048566
The process whose specific outcome is the progression of the gut over time, from its formation to the mature structure during embryonic development. The gut is the region of the digestive tract extending from the beginning of the intestines to the anus.
|
5 | P01375 (/IEP) P01375 (/IEP) P01375 (/IEP) P01375 (/IEP) P01375 (/IEP) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of cytokine secretion GO:0050715
Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of inflammatory response GO:0050729
Any process that activates or increases the frequency, rate or extent of the inflammatory response.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Positive regulation of fractalkine biosynthetic process GO:0050754
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of fractalkine, a chemokine involved in the control of the key regulatory mechanisms of cell trafficking at sites of inflammation.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Positive regulation of phagocytosis GO:0050766
Any process that activates or increases the frequency, rate or extent of phagocytosis.
|
5 | P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) |
Negative regulation of neurogenesis GO:0050768
Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the generation of cells within the nervous system.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Regulation of insulin secretion GO:0050796
Any process that modulates the frequency, rate or extent of the regulated release of insulin.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of synaptic transmission GO:0050806
Any process that activates or increases the frequency, rate or extent of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Regulation of synapse organization GO:0050807
Any process that modulates the physical form of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Cognition GO:0050890
The operation of the mind by which an organism becomes aware of objects of thought or perception; it includes the mental activities associated with thinking, learning, and memory.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Leukocyte tethering or rolling GO:0050901
Transient adhesive interactions between leukocytes and endothelial cells lining blood vessels. Carbohydrates on circulating leukocytes bind selectins on the vessel wall causing the leukocytes to slow down and roll along the inner surface of the vessel wall. During this rolling motion, transitory bonds are formed and broken between selectins and their ligands. Typically the first step in cellular extravasation (the movement of leukocytes out of the circulatory system, towards the site of tissue damage or infection).
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Negative regulation of lipid catabolic process GO:0050995
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of membrane protein ectodomain proteolysis GO:0051044
Any process that activates or increases the frequency, rate or extent of membrane protein ectodomain peptidolysis.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of DNA-binding transcription factor activity GO:0051091
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
|
5 | P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) |
Positive regulation of nitrogen compound metabolic process GO:0051173
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving nitrogen or nitrogenous compounds.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Response to glucocorticoid GO:0051384
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Regulation of synaptic transmission, glutamatergic GO:0051966
Any process that modulates the frequency, rate or extent of glutamatergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Positive regulation of glial cell proliferation GO:0060252
Any process that activates or increases the rate or extent of glial cell proliferation.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of glial cell proliferation GO:0060252
Any process that activates or increases the rate or extent of glial cell proliferation.
|
5 | P01375 (/IGI) P01375 (/IGI) P01375 (/IGI) P01375 (/IGI) P01375 (/IGI) |
Positive regulation of vitamin D biosynthetic process GO:0060557
Any process that increases the rate, frequency or extent of a vitamin D biosynthetic process. Vitamin D biosynthesis is the chemical reactions and pathways resulting in the formation of vitamin D, any of a group of related, fat-soluble compounds that are derived from delta-5,7 steroids and play a central role in calcium metabolism. Specific forms of vitamin D include calciferol (ergocalciferol; vitamin D2) and cholecalciferol (calciol; vitamin D3).
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of calcidiol 1-monooxygenase activity GO:0060559
Any process that increases the rate, frequency or extent of calcidiol 1-monooxygenase activity. Calcidiol 1-monooxygenase activity is the catalysis of the reaction: calcidiol + NADPH + H+ + O2 = calcitriol + NADP+ + H2O.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Negative regulation of branching involved in lung morphogenesis GO:0061048
Any process that decreases the rate, frequency, or extent of the process in which a highly ordered sequence of patterning events generates the branched structures of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
5 | P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) |
Positive regulation of calcineurin-NFAT signaling cascade GO:0070886
Any process that activates or increases the frequency, rate or extent of signaling via the calcineurin-NFAT signaling cascade.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Cellular response to nicotine GO:0071316
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Cellular response to organic cyclic compound GO:0071407
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Death-inducing signaling complex assembly GO:0071550
A process of protein complex assembly in which the arrangement and bonding together of the set of components that form the protein complex is mediated by a death domain (DD) interaction, as part of the extrinsic apoptotic signaling pathway.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Positive regulation of mononuclear cell migration GO:0071677
Any process that increases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body.
|
5 | P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) P01375 (/NAS) |
Positive regulation of podosome assembly GO:0071803
Any process that activates or increases the rate or extent of podosome assembly.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Protein localization to plasma membrane GO:0072659
A process in which a protein is transported to, or maintained in, a specific location in the plasma membrane.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of chemokine secretion GO:0090197
Any process that increases the rate, frequency or extent of chemokine secretion, the regulated release of chemokines from a cell.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Necroptotic signaling pathway GO:0097527
A series of molecular signals which triggers the necroptotic death of a cell. The pathway starts with reception of a signal, is characterized by activation of receptor-interacting serine/threonine-protein kinase 1 and/or 3 (RIPK1/3, also called RIP1/3), and ends when the execution phase of necroptosis is triggered.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of neuroinflammatory response GO:0150078
Any process that activates or increases the frequency, rate or extent of neuroinflammatory response.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Negative regulation of amyloid-beta clearance GO:1900222
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid-beta clearance.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Positive regulation of NIK/NF-kappaB signaling GO:1901224
Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of superoxide dismutase activity GO:1901671
Any process that activates or increases the frequency, rate or extent of superoxide dismutase activity.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of amyloid-beta formation GO:1902004
Any process that activates or increases the frequency, rate or extent of amyloid-beta formation.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Positive regulation of protein localization to plasma membrane GO:1903078
Any process that activates or increases the frequency, rate or extent of protein localization to plasma membrane.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Regulation of establishment of endothelial barrier GO:1903140
Any process that modulates the frequency, rate or extent of establishment of endothelial barrier.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Negative regulation of bicellular tight junction assembly GO:1903347
Any process that stops, prevents or reduces the frequency, rate or extent of tight junction assembly.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of leukocyte adhesion to vascular endothelial cell GO:1904996
Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to vascular endothelial cell.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of leukocyte adhesion to arterial endothelial cell GO:1904999
Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to arterial endothelial cell.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of protein localization to cell surface GO:2000010
Any process that activates or increases the frequency, rate or extent of protein localization to the cell surface.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of ceramide biosynthetic process GO:2000304
Any process that activates or increases the frequency, rate or extent of ceramide biosynthetic process.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Positive regulation of blood microparticle formation GO:2000334
Any process that activates or increases the frequency, rate or extent of blood microparticle formation.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of chemokine (C-X-C motif) ligand 2 production GO:2000343
Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Regulation of endothelial cell apoptotic process GO:2000351
Any process that modulates the frequency, rate or extent of endothelial cell apoptotic process.
|
5 | P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) P01375 (/IMP) |
Positive regulation of interleukin-6 secretion GO:2000778
Any process that activates or increases the frequency, rate or extent of interleukin-6 secretion.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Positive regulation of interleukin-6 secretion GO:2000778
Any process that activates or increases the frequency, rate or extent of interleukin-6 secretion.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Positive regulation of endothelial cell apoptotic process GO:2000353
Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
|
4 | B3GDZ6 (/IMP) B3GDZ6 (/IMP) P23563 (/IMP) P23563 (/IMP) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
3 | P06804 (/TAS) P06804 (/TAS) P16599 (/TAS) |
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
3 | P06804 (/IDA) P06804 (/IDA) P16599 (/IDA) |
Positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123
Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling.
|
3 | P06804 (/IGI) P06804 (/IGI) P16599 (/IGI) |
Negative regulation of glucose import GO:0046325
Any process that stops, prevents, or reduces the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
|
3 | P06804 (/IDA) P06804 (/IDA) P16599 (/IDA) |
Positive regulation of synaptic transmission GO:0050806
Any process that activates or increases the frequency, rate or extent of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.
|
3 | P06804 (/IMP) P06804 (/IMP) P16599 (/IMP) |
Positive regulation of protein localization to plasma membrane GO:1903078
Any process that activates or increases the frequency, rate or extent of protein localization to plasma membrane.
|
3 | P06804 (/IMP) P06804 (/IMP) P16599 (/IMP) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
2 | P06804 (/ISO) P06804 (/ISO) |
MAPK cascade GO:0000165
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Activation of MAPKKK activity GO:0000185
Any process that initiates the activity of the inactive enzyme MAP kinase kinase kinase (MAPKKK).
|
2 | P06804 (/ISO) P06804 (/ISO) |
Activation of MAPK activity GO:0000187
The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
|
2 | P06804 (/ISO) P06804 (/ISO) |
Microglial cell activation GO:0001774
The change in morphology and behavior of a microglial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Cell activation GO:0001775
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of cytokine production GO:0001819
Any process that activates or increases the frequency, rate or extent of production of a cytokine.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Regulation of protein phosphorylation GO:0001932
Any process that modulates the frequency, rate or extent of addition of phosphate groups into an amino acid in a protein.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Negative regulation of endothelial cell proliferation GO:0001937
Any process that stops, prevents, or reduces the rate or extent of endothelial cell proliferation.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Negative regulation of L-glutamate import across plasma membrane GO:0002037
Any process that stops, prevents or reduces the frequency, rate or extent of L-glutamate import into a cell.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Chronic inflammatory response to antigenic stimulus GO:0002439
A chronic inflammatory response to an antigenic stimulus. A chronic inflammatory response persists indefinitely during days, weeks, or months in the life of an individual.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Negative regulation of cytokine secretion involved in immune response GO:0002740
Any process that stops, prevents, or reduces the frequency, rate, or extent of cytokine secretion contributing to an immune response.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of chronic inflammatory response to antigenic stimulus GO:0002876
Any process that activates or increases the frequency, rate, or extent of a chronic inflammatory response to an antigenic stimulus.
|
2 | P06804 (/IGI) P06804 (/IGI) |
Positive regulation of humoral immune response mediated by circulating immunoglobulin GO:0002925
Any process that activates or increases the frequency, rate, or extent of a humoral immune response mediated by circulating immunoglobulin.
|
2 | P06804 (/IGI) P06804 (/IGI) |
Glucose metabolic process GO:0006006
The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006919
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Defense response GO:0006952
Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.
|
2 | P06804 (/IMP) P06804 (/IMP) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
2 | P06804 (/IGI) P06804 (/IGI) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Humoral immune response GO:0006959
An immune response mediated through a body fluid.
|
2 | P06804 (/IMP) P06804 (/IMP) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
2 | P06804 (/ISO) P06804 (/ISO) |
JNK cascade GO:0007254
An intracellular protein kinase cascade containing at least a JNK (a MAPK), a JNKK (a MAPKK) and a JUN3K (a MAP3K). The cascade can also contain an additional tier: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
|
2 | P06804 (/IGI) P06804 (/IGI) |
Multicellular organism development GO:0007275
The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
|
2 | P06804 (/IMP) P06804 (/IMP) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
2 | P06804 (/TAS) P06804 (/TAS) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Extrinsic apoptotic signaling pathway via death domain receptors GO:0008625
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with a ligand binding to a death domain receptor on the cell surface, and ends when the execution phase of apoptosis is triggered.
|
2 | P06804 (/IGI) P06804 (/IGI) |
Extrinsic apoptotic signaling pathway via death domain receptors GO:0008625
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with a ligand binding to a death domain receptor on the cell surface, and ends when the execution phase of apoptosis is triggered.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Intrinsic apoptotic signaling pathway in response to DNA damage GO:0008630
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the detection of DNA damage, and ends when the execution phase of apoptosis is triggered.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Response to virus GO:0009615
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Animal organ morphogenesis GO:0009887
Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
|
2 | P06804 (/IMP) P06804 (/IMP) |
Response to organic substance GO:0010033
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Negative regulation of alkaline phosphatase activity GO:0010693
Any process that decreases the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Calcium-mediated signaling GO:0019722
Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Extracellular matrix organization GO:0030198
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Osteoclast differentiation GO:0030316
The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
|
2 | P06804 (/IGI) P06804 (/IGI) |
Sequestering of triglyceride GO:0030730
The process of binding or confining any triester of glycerol such that it is separated from other components of a biological system.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Cortical actin cytoskeleton organization GO:0030866
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of actin-based cytoskeletal structures in the cell cortex, i.e. just beneath the plasma membrane.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of protein complex assembly GO:0031334
Any process that activates or increases the frequency, rate or extent of protein complex assembly.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of fever generation GO:0031622
Any process that activates or increases the frequency, rate, or extent of fever generation.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Negative regulation of myelination GO:0031642
Any process that stops, prevents, or reduces the frequency, rate or extent of the formation of a myelin sheath around nerve axons.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Negative regulation of interleukin-6 production GO:0032715
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of chemokine production GO:0032722
Any process that activates or increases the frequency, rate, or extent of chemokine production.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of interferon-gamma production GO:0032729
Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
|
2 | P06804 (/IGI) P06804 (/IGI) |
Positive regulation of interleukin-18 production GO:0032741
Any process that activates or increases the frequency, rate, or extent of interleukin-18 production.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of interleukin-6 production GO:0032755
Any process that activates or increases the frequency, rate, or extent of interleukin-6 production.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of interleukin-8 production GO:0032757
Any process that activates or increases the frequency, rate, or extent of interleukin-8 production.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Receptor biosynthetic process GO:0032800
The chemical reactions and pathways resulting in the formation of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Tumor necrosis factor-mediated signaling pathway GO:0033209
A series of molecular signals initiated by the binding of a tumor necrosis factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Tumor necrosis factor-mediated signaling pathway GO:0033209
A series of molecular signals initiated by the binding of a tumor necrosis factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of heterotypic cell-cell adhesion GO:0034116
Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Toll-like receptor 3 signaling pathway GO:0034138
Any series of molecular signals generated as a consequence of binding to toll-like receptor 3.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Negative regulation of myosin-light-chain-phosphatase activity GO:0035509
Any process that stops, prevents, or reduces the frequency, rate or extent of myosin-light-chain-phosphatase activity.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Vasodilation GO:0042311
An increase in the internal diameter of blood vessels, especially arterioles or capillaries, due to relaxation of smooth muscle cells that line the vessels, and usually resulting in a decrease in blood pressure.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of tyrosine phosphorylation of STAT protein GO:0042531
Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Defense response to bacterium GO:0042742
Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of programmed cell death GO:0043068
Any process that activates or increases the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Regulation of I-kappaB kinase/NF-kappaB signaling GO:0043122
Any process that modulates I-kappaB kinase/NF-kappaB signaling.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123
Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Negative regulation of protein complex disassembly GO:0043242
Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of protein complex disassembly GO:0043243
Any process that activates or increases the frequency, rate or extent of protein complex disassembly, the disaggregation of a protein complex into its constituent components.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043280
Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Protein kinase B signaling GO:0043491
A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of JUN kinase activity GO:0043507
Any process that activates or increases the frequency, rate or extent of JUN kinase activity.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Negative regulation of growth of symbiont in host GO:0044130
Any process in which the symbiont stops, prevents or reduces its increase in size or mass within the cells or tissues of the host organism. The host is defined as the larger of the organisms involved in the symbiotic interaction.
|
2 | P06804 (/IGI) P06804 (/IGI) |
Negative regulation of viral genome replication GO:0045071
Any process that stops, prevents, or reduces the frequency, rate or extent of viral genome replication.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of chemokine biosynthetic process GO:0045080
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of chemokines.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Cellular extravasation GO:0045123
The migration of a leukocyte from the blood vessels into the surrounding tissue.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of interleukin-6 biosynthetic process GO:0045410
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-6.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of interleukin-8 biosynthetic process GO:0045416
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of nitric oxide biosynthetic process GO:0045429
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Regulation of fat cell differentiation GO:0045598
Any process that modulates the frequency, rate or extent of adipocyte differentiation.
|
2 | P23563 (/IGI) P23563 (/IGI) |
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Negative regulation of myoblast differentiation GO:0045662
Any process that stops, prevents, or reduces the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
2 | P06804 (/IMP) P06804 (/IMP) |
Negative regulation of osteoblast differentiation GO:0045668
Any process that stops, prevents, or reduces the frequency, rate or extent of osteoblast differentiation.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Regulation of osteoclast differentiation GO:0045670
Any process that modulates the frequency, rate or extent of osteoclast differentiation.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of osteoclast differentiation GO:0045672
Any process that activates or increases the frequency, rate or extent of osteoclast differentiation.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of protein catabolic process GO:0045732
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of action potential GO:0045760
Any process that activates or increases the frequency, rate or extent of action potential creation, propagation or termination. This typically occurs via modulation of the activity or expression of voltage-gated ion channels.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of cell adhesion GO:0045785
Any process that activates or increases the frequency, rate or extent of cell adhesion.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of mitotic nuclear division GO:0045840
Any process that activates or increases the frequency, rate or extent of mitosis.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of protein kinase activity GO:0045860
Any process that activates or increases the frequency, rate or extent of protein kinase activity.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Negative regulation of mitotic cell cycle GO:0045930
Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of translational initiation by iron GO:0045994
Any process involving iron that activates or increases the rate of translational initiation.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Negative regulation of glucose import GO:0046325
Any process that stops, prevents, or reduces the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of JNK cascade GO:0046330
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of JNK cascade GO:0046330
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade.
|
2 | P06804 (/IGI) P06804 (/IGI) |
Positive regulation of receptor signaling pathway via JAK-STAT GO:0046427
Any process that activates or increases the frequency, rate or extent of the JAK-STAT signaling pathway activity.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Regulation of protein secretion GO:0050708
Any process that modulates the frequency, rate or extent of the controlled release of a protein from a cell.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of cytokine secretion GO:0050715
Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Regulation of inflammatory response GO:0050727
Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of inflammatory response GO:0050729
Any process that activates or increases the frequency, rate or extent of the inflammatory response.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of fractalkine biosynthetic process GO:0050754
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of fractalkine, a chemokine involved in the control of the key regulatory mechanisms of cell trafficking at sites of inflammation.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of phagocytosis GO:0050766
Any process that activates or increases the frequency, rate or extent of phagocytosis.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Regulation of insulin secretion GO:0050796
Any process that modulates the frequency, rate or extent of the regulated release of insulin.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of synaptic transmission GO:0050806
Any process that activates or increases the frequency, rate or extent of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Regulation of synapse organization GO:0050807
Any process that modulates the physical form of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).
|
2 | P06804 (/IMP) P06804 (/IMP) |
Defense response to Gram-positive bacterium GO:0050830
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
|
2 | P06804 (/IGI) P06804 (/IGI) |
Leukocyte migration GO:0050900
The movement of a leukocyte within or between different tissues and organs of the body.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Leukocyte tethering or rolling GO:0050901
Transient adhesive interactions between leukocytes and endothelial cells lining blood vessels. Carbohydrates on circulating leukocytes bind selectins on the vessel wall causing the leukocytes to slow down and roll along the inner surface of the vessel wall. During this rolling motion, transitory bonds are formed and broken between selectins and their ligands. Typically the first step in cellular extravasation (the movement of leukocytes out of the circulatory system, towards the site of tissue damage or infection).
|
2 | P06804 (/ISO) P06804 (/ISO) |
Detection of mechanical stimulus involved in sensory perception of pain GO:0050966
The series of events involved in the perception of pain in which a mechanical stimulus is received and converted into a molecular signal.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Negative regulation of lipid catabolic process GO:0050995
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Regulation of immunoglobulin secretion GO:0051023
Any process that modulates the frequency, rate or extent of the regulated release of immunoglobulins from a cell.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of membrane protein ectodomain proteolysis GO:0051044
Any process that activates or increases the frequency, rate or extent of membrane protein ectodomain peptidolysis.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of DNA-binding transcription factor activity GO:0051091
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of nitrogen compound metabolic process GO:0051173
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving nitrogen or nitrogenous compounds.
|
2 | P06804 (/IGI) P06804 (/IGI) |
Positive regulation of protein transport GO:0051222
Any process that activates or increases the frequency, rate or extent of the directed movement of a protein into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Response to glucocorticoid GO:0051384
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of hair follicle development GO:0051798
Any process that activates or increases the frequency, rate or extent of hair follicle development.
|
2 | P06804 (/IMP) P06804 (/IMP) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of glial cell proliferation GO:0060252
Any process that activates or increases the rate or extent of glial cell proliferation.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of vitamin D biosynthetic process GO:0060557
Any process that increases the rate, frequency or extent of a vitamin D biosynthetic process. Vitamin D biosynthesis is the chemical reactions and pathways resulting in the formation of vitamin D, any of a group of related, fat-soluble compounds that are derived from delta-5,7 steroids and play a central role in calcium metabolism. Specific forms of vitamin D include calciferol (ergocalciferol; vitamin D2) and cholecalciferol (calciol; vitamin D3).
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of calcidiol 1-monooxygenase activity GO:0060559
Any process that increases the rate, frequency or extent of calcidiol 1-monooxygenase activity. Calcidiol 1-monooxygenase activity is the catalysis of the reaction: calcidiol + NADPH + H+ + O2 = calcitriol + NADP+ + H2O.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Epithelial cell proliferation involved in salivary gland morphogenesis GO:0060664
The multiplication or reproduction of epithelial cells of the submandibular salivary gland, resulting in the expansion of a cell population and the shaping of the gland.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Regulation of branching involved in salivary gland morphogenesis GO:0060693
Any process that modulates the rate, frequency, or extent of branching morphogenesis in the salivary gland epithelium.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Regulation of branching involved in salivary gland morphogenesis GO:0060693
Any process that modulates the rate, frequency, or extent of branching morphogenesis in the salivary gland epithelium.
|
2 | P06804 (/IMP) P06804 (/IMP) |
Negative regulation of branching involved in lung morphogenesis GO:0061048
Any process that decreases the rate, frequency, or extent of the process in which a highly ordered sequence of patterning events generates the branched structures of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of calcineurin-NFAT signaling cascade GO:0070886
Any process that activates or increases the frequency, rate or extent of signaling via the calcineurin-NFAT signaling cascade.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Cellular response to amino acid stimulus GO:0071230
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Cellular response to nicotine GO:0071316
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nicotine stimulus.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Cellular response to organic cyclic compound GO:0071407
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of podosome assembly GO:0071803
Any process that activates or increases the rate or extent of podosome assembly.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Endothelial cell apoptotic process GO:0072577
Any apoptotic process in an endothelial cell. An endothelial cell comprises the outermost layer or lining of anatomical structures and can be squamous or cuboidal.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Protein localization to plasma membrane GO:0072659
A process in which a protein is transported to, or maintained in, a specific location in the plasma membrane.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of chemokine secretion GO:0090197
Any process that increases the rate, frequency or extent of chemokine secretion, the regulated release of chemokines from a cell.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Apoptotic signaling pathway GO:0097190
A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
2 | P06804 (/IGI) P06804 (/IGI) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Necroptotic signaling pathway GO:0097527
A series of molecular signals which triggers the necroptotic death of a cell. The pathway starts with reception of a signal, is characterized by activation of receptor-interacting serine/threonine-protein kinase 1 and/or 3 (RIPK1/3, also called RIP1/3), and ends when the execution phase of necroptosis is triggered.
|
2 | P06804 (/IGI) P06804 (/IGI) |
Necroptotic signaling pathway GO:0097527
A series of molecular signals which triggers the necroptotic death of a cell. The pathway starts with reception of a signal, is characterized by activation of receptor-interacting serine/threonine-protein kinase 1 and/or 3 (RIPK1/3, also called RIP1/3), and ends when the execution phase of necroptosis is triggered.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Negative regulation of amyloid-beta clearance GO:1900222
Any process that stops, prevents or reduces the frequency, rate or extent of amyloid-beta clearance.
|
2 | P06804 (/IGI) P06804 (/IGI) |
Positive regulation of NIK/NF-kappaB signaling GO:1901224
Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling.
|
2 | P06804 (/IMP) P06804 (/IMP) |
Positive regulation of NIK/NF-kappaB signaling GO:1901224
Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of superoxide dismutase activity GO:1901671
Any process that activates or increases the frequency, rate or extent of superoxide dismutase activity.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of amyloid-beta formation GO:1902004
Any process that activates or increases the frequency, rate or extent of amyloid-beta formation.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of protein localization to plasma membrane GO:1903078
Any process that activates or increases the frequency, rate or extent of protein localization to plasma membrane.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Regulation of establishment of endothelial barrier GO:1903140
Any process that modulates the frequency, rate or extent of establishment of endothelial barrier.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Negative regulation of bicellular tight junction assembly GO:1903347
Any process that stops, prevents or reduces the frequency, rate or extent of tight junction assembly.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of vascular smooth muscle cell proliferation GO:1904707
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of leukocyte adhesion to vascular endothelial cell GO:1904996
Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to vascular endothelial cell.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of leukocyte adhesion to arterial endothelial cell GO:1904999
Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to arterial endothelial cell.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of protein localization to cell surface GO:2000010
Any process that activates or increases the frequency, rate or extent of protein localization to the cell surface.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of blood microparticle formation GO:2000334
Any process that activates or increases the frequency, rate or extent of blood microparticle formation.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of chemokine (C-X-C motif) ligand 2 production GO:2000343
Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Regulation of endothelial cell apoptotic process GO:2000351
Any process that modulates the frequency, rate or extent of endothelial cell apoptotic process.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Regulation of reactive oxygen species metabolic process GO:2000377
Any process that modulates the frequency, rate or extent of reactive oxygen species metabolic process.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Positive regulation of interleukin-6 secretion GO:2000778
Any process that activates or increases the frequency, rate or extent of interleukin-6 secretion.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Positive regulation of estradiol secretion GO:2000866
Any process that activates or increases the frequency, rate or extent of estradiol secretion.
|
2 | P23563 (/IDA) P23563 (/IDA) |
Negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
1 | P16599 (/IEP) |
Cell activation GO:0001775
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
1 | P16599 (/IDA) |
Negative regulation of L-glutamate import across plasma membrane GO:0002037
Any process that stops, prevents or reduces the frequency, rate or extent of L-glutamate import into a cell.
|
1 | P16599 (/IDA) |
Acute inflammatory response GO:0002526
Inflammation which comprises a rapid, short-lived, relatively uniform response to acute injury or antigenic challenge and is characterized by accumulations of fluid, plasma proteins, and granulocytic leukocytes. An acute inflammatory response occurs within a matter of minutes or hours, and either resolves within a few days or becomes a chronic inflammatory response.
|
1 | P16599 (/IEP) |
Skeletal muscle contraction GO:0003009
A process in which force is generated within skeletal muscle tissue, resulting in a change in muscle geometry. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. In the skeletal muscle, the muscle contraction takes advantage of an ordered sarcomeric structure and in most cases it is under voluntary control.
|
1 | P16599 (/IEP) |
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
1 | P16599 (/IDA) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
1 | P16599 (/IDA) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
1 | P16599 (/IDA) |
Circadian rhythm GO:0007623
Any biological process in an organism that recurs with a regularity of approximately 24 hours.
|
1 | P16599 (/IEP) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
1 | P16599 (/IDA) |
Response to radiation GO:0009314
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation.
|
1 | P16599 (/IEP) |
Response to mechanical stimulus GO:0009612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
1 | P16599 (/IEP) |
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
|
1 | P16599 (/IMP) |
Response to activity GO:0014823
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an activity stimulus.
|
1 | P16599 (/IEP) |
Calcium-mediated signaling GO:0019722
Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions.
|
1 | P16599 (/IDA) |
Negative regulation of myelination GO:0031642
Any process that stops, prevents, or reduces the frequency, rate or extent of the formation of a myelin sheath around nerve axons.
|
1 | P16599 (/IMP) |
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
1 | P16599 (/IEP) |
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
1 | P16599 (/IMP) |
Positive regulation of interleukin-18 production GO:0032741
Any process that activates or increases the frequency, rate, or extent of interleukin-18 production.
|
1 | P16599 (/IMP) |
Toll-like receptor 3 signaling pathway GO:0034138
Any series of molecular signals generated as a consequence of binding to toll-like receptor 3.
|
1 | P16599 (/IMP) |
Vasodilation GO:0042311
An increase in the internal diameter of blood vessels, especially arterioles or capillaries, due to relaxation of smooth muscle cells that line the vessels, and usually resulting in a decrease in blood pressure.
|
1 | P16599 (/IMP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | P16599 (/IEP) |
Positive regulation of tyrosine phosphorylation of STAT protein GO:0042531
Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
|
1 | P16599 (/IDA) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
1 | P16599 (/IMP) |
Positive regulation of interleukin-6 biosynthetic process GO:0045410
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-6.
|
1 | P16599 (/IDA) |
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
|
1 | P16599 (/IDA) |
Positive regulation of action potential GO:0045760
Any process that activates or increases the frequency, rate or extent of action potential creation, propagation or termination. This typically occurs via modulation of the activity or expression of voltage-gated ion channels.
|
1 | P16599 (/IDA) |
Positive regulation of mitotic nuclear division GO:0045840
Any process that activates or increases the frequency, rate or extent of mitosis.
|
1 | P16599 (/IMP) |
Positive regulation of receptor signaling pathway via JAK-STAT GO:0046427
Any process that activates or increases the frequency, rate or extent of the JAK-STAT signaling pathway activity.
|
1 | P16599 (/IDA) |
Positive regulation of fractalkine biosynthetic process GO:0050754
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of fractalkine, a chemokine involved in the control of the key regulatory mechanisms of cell trafficking at sites of inflammation.
|
1 | P16599 (/IDA) |
Detection of mechanical stimulus involved in sensory perception of pain GO:0050966
The series of events involved in the perception of pain in which a mechanical stimulus is received and converted into a molecular signal.
|
1 | P16599 (/IMP) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
1 | P16599 (/IMP) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
1 | P16599 (/IEP) |
Cellular response to retinoic acid GO:0071300
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus.
|
1 | P16599 (/IEP) |
Protein localization to plasma membrane GO:0072659
A process in which a protein is transported to, or maintained in, a specific location in the plasma membrane.
|
1 | C1K3N5 (/IMP) |
Positive regulation of chemokine secretion GO:0090197
Any process that increases the rate, frequency or extent of chemokine secretion, the regulated release of chemokines from a cell.
|
1 | P16599 (/IDA) |
Cellular response to amyloid-beta GO:1904646
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a amyloid-beta stimulus.
|
1 | P16599 (/IEP) |
Response to gold nanoparticle GO:1990268
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gold nanoparticle stimulus.
|
1 | P16599 (/IEP) |
Positive regulation of interleukin-6 secretion GO:2000778
Any process that activates or increases the frequency, rate or extent of interleukin-6 secretion.
|
1 | P16599 (/IDA) |
There are 25 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
17 |
P01375 (/IDA)
P01375 (/IDA)
P01375 (/IDA)
P01375 (/IDA)
P01375 (/IDA)
P06804 (/IDA)
P06804 (/IDA)
P16599 (/IDA)
Q06599 (/IDA)
Q06599 (/IDA)
(7 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
9 | Q06599 (/NAS) Q06599 (/NAS) Q06599 (/NAS) Q06599 (/NAS) Q06599 (/NAS) Q06599 (/NAS) Q06599 (/NAS) Q06599 (/NAS) Q06599 (/NAS) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
7 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P06804 (/IDA) P06804 (/IDA) |
Phagocytic cup GO:0001891
An invagination of the cell membrane formed by an actin dependent process during phagocytosis. Following internalization it is converted into a phagosome.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
5 | P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) P01375 (/TAS) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
5 | P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) P01375 (/IDA) |
Recycling endosome GO:0055037
An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane.
|
5 | P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) P01375 (/ISS) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
3 | P06804 (/IDA) P06804 (/IDA) P16599 (/IDA) |
Phagocytic cup GO:0001891
An invagination of the cell membrane formed by an actin dependent process during phagocytosis. Following internalization it is converted into a phagosome.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
2 | P06804 (/TAS) P06804 (/TAS) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
|
2 | P06804 (/TAS) P06804 (/TAS) |
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
2 | P06804 (/ISO) P06804 (/ISO) |
Recycling endosome GO:0055037
An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane.
|
2 | P06804 (/IDA) P06804 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | P16599 (/IDA) |
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
|
1 | P16599 (/IDA) |